FDA Approves Dual-Energy Catheter Ablation Platform - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Approves Dual-Energy Catheter Ablation Platform

The platform integrates with the CARTO ecosystem and enables physicians to use either pulsed field or radiofrequency energy based on patient anatomy and case complexity.

  • By

  • Kathryn Wighton

  • July 8, 2026

  • 2 min

Share

  • 1

    The FDA has approved the Dual Energy THERMOCOOL SMARTTOUCH SF Platform from Johnson & Johnson for catheter ablation.

  • 2

    This platform allows electrophysiologists to deliver both pulsed field and radiofrequency energy through a single catheter.

  • 3

    The platform is built on the existing THERMOCOOL SMARTTOUCH SF catheter platform, used in over one million US patient treatments.

  • 4

    The Dual Energy platform integrates with the CARTO ecosystem for enhanced mapping, imaging, and guidance.

  • 5

    First US procedures using the platform are expected to begin this summer as part of a phased commercial rollout.

Original Source(s)

FDA Approves Dual-Energy Catheter Ablation Platform

  • by Kathryn Wighton

  • July 8, 2026

Related Content

May Lower RFR Signal Repeat Revascularization?

Patients with lower nonischemic resting full-cycle ratio values had more repeat revascularizations despite similar 2-year major cardiovascular event rates.

Could Pregnancy Complications Predict CVD Risk?

Investigators found that adding pregnancy-related and female-specific factors modestly improved postpartum cardiovascular risk prediction compared with traditional risk factors alone.

Heartbeat-powered pacemaker may pave way for self-sustaining devices

A triboelectric nanogenerator–supported pacemaker shows efficacy in a preclinical swine study.